General Hospital Krusevac

Kruševac 37000

0 studies enrolling now · 3 studies all time

What they study most

Diabetic Kidney Disease, Immunoglobulin A (IgA) Nephropathy, Lupus Nephritis

Studies at this site

• Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy — Completed
• Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease — Completed
• Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN) — Stopped early